Remacro Machinery & Technology (WUJIANG) Co., Ltd.
USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A47C (CHAIRS; SOFAS; Beds).
The verdict
According to USPTO PatentsView, Remacro ranks #33,045 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.
- #33,045
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (17.3/100)
- 6.0
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R33045 · Foreign Corporation #33,045 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #33,045/49,997
- PHOTO-FINISH Regenxbio
- CPC-NARROW A47C · 3 areas
- INNOV-LOW 17.3/100
- CLAIMS-SPARSE 6.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Regenxbio Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Remacro’s 17.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Remacro
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Remacro Machinery &… · this assignee 17
Remacro Machinery &… · this assignee
17 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Remacro's Innovation Score is 17.3/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Remacro?
Each dot is one of Remacro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Remacro’s own 6.0 claims/patent is at or below the 16.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Remacro's grants concentrate
Remacro Machinery & Technology (WUJIANG) Co., Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A47C (CHAIRS; SOFAS; Beds). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2016. By volume, Remacro sits between Regenxbio Inc. and Remo, Inc..
Who files at Remacro's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Regenxbio
Regenxbio Inc.
8 patents
- Regwez
Regwez, Inc.
8 patents
- Reinhold Industri…
Reinhold Industries, Inc.
8 patents
- Reis Group Holdin…
Reis Group Holding GMBH & Co. KG
8 patents
- Remedy Pharmaceut…
Remedy Pharmaceuticals, Inc.
8 patents
- Remegen
Remegen Co., Ltd.
8 patents
- Remis Gesellschaf…
Remis Gesellschaft Fuer Entwicklung UND Vertrieb VON Technischen Elementen MBH
8 patents
- Remo
Remo, Inc.
8 patents
- Remacro Machinery… ◀
Remacro Machinery & Technology (WUJIANG) Co., Ltd.
8 patents
What this shows Remacro holds 8 patents at rank #33,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Remacro
By rank, the assignees closest to #33,002 in granted patent volume.
- Regenxbio Inc. #32,998 · 8 patents
- Regwez, Inc. #32,999 · 8 patents
- Reinhold Industries, Inc. #33,000 · 8 patents
- Reis Group Holding GMBH & Co. KG #33,001 · 8 patents
- Remedy Pharmaceuticals, Inc. #33,003 · 8 patents
- Remegen Co., Ltd. #33,004 · 8 patents
- Remis Gesellschaft Fuer Entwicklung UND Vertrieb VON Technischen Elementen MBH #33,005 · 8 patents
- Remo, Inc. #33,006 · 8 patents
Leaders in A47C (Chairs)
Other assignees with the most granted patents in Remacro's primary technology class.
Remacro's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
17 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 2 | 25.0% |
| 2018 | 3 | 37.5% |
| 2019 | 2 | 25.0% |
Which technologies does Remacro Machinery & Technology (WUJIANG) Co., Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Remacro Machinery & Technology (WUJIANG) Co., Ltd.'s patent record in context - here's where to go next.
- Remacro Machinery & Technology (WUJIANG) Co., Ltd.'s lead technology class is A47C (CHAIRS; SOFAS; Beds), 100% of its portfolio - see every assignee active in that class. Explore A47C
- Ranked #33,045 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Remacro Machinery & Technology (WUJIANG) Co., Ltd. against Regenxbio Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 17.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.